ABIO NASDAQ
ARCA biopharma, Inc.
1W: +10.8%
1M: +55.8%
3M: +24.6%
1Y: +123.8%
3Y: +51.1%
5Y: -11.7%
$28.80
Last traded 2024-08-30 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$489M
+0.0% ▲
5Y CAGR: +124.7%
Total Liabilities
$17M
+0.0% ▲
5Y CAGR: +78.3%
Shareholders Equity
$472M
+0.0% ▲
5Y CAGR: +128.3%
Cash & Investments
$337M
+0.0% ▲
5Y CAGR: +109.4%
Total Debt
$2M
+0.0% ▲
5Y CAGR: +138.6%
Net Debt
-$45M
+0.0% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $49M | $53M | $42M | $37M | $47M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $290M |
| Cash & ST Investments | $49M | $53M | $42M | $37M | $337M |
| Net Receivables | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $897K | $1M | $254K | $161K | $7M |
| Total Current Assets | $50M | $54M | $43M | $38M | $344M |
| Property, Plant & Equip. | $449K | $485K | $368K | $257K | $2M |
| Goodwill & Intangibles | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Assets | $12K | $18K | $18K | $12K | $143M |
| Total Non-Current Assets | $461K | $503K | $386K | $269K | $145M |
| Total Assets | $50M | $55M | $43M | $38M | $489M |
| — Liabilities — | |||||
| Accounts Payable | $2M | $1M | $334K | $362K | $4M |
| Short-Term Debt | $41K | $100K | $103K | $0 | $619K |
| Deferred Revenue | $0 | -$100K | -$103K | $0 | $0 |
| Other Current Liabilities | $774K | $925K | $173K | $100K | $15M |
| Total Current Liabilities | $3M | $3M | $1M | $637K | $15M |
| Long-Term Debt | $0 | $383K | $280K | $204K | $1M |
| Other Non-Current Liab. | $0 | -$383K | -$280K | -$204K | $0 |
| Total Non-Current Liabilities | $409K | $383K | $280K | $204K | $1M |
| Total Liabilities | $4M | $4M | $1M | $841K | $17M |
| — Equity — | |||||
| Common Stock | $10K | $14K | $14K | $14K | $49K |
| Retained Earnings | -$154M | -$173M | -$183M | -$189M | -$189M |
| Accumulated OCI | $0 | $0 | $0 | $0 | $546K |
| Total Stockholders Equity | $47M | $51M | $42M | $37M | $472M |
| Total Liabilities & Equity | $50M | $55M | $43M | $38M | $489M |
| — Key Metrics — | |||||
| Total Debt | $409K | $383K | $280K | $204K | $2M |
| Net Debt | -$49M | -$53M | -$42M | -$37M | -$45M |
| Total Investments | $0 | $0 | $0 | $0 | $290M |